Testosterone Therapy: What the Evidence Shows

Testosterone therapy is one of the most discussed and most debated treatments in hormone medicine. This page summarizes, in plain language, what major clinical guidelines and the broad body of evidence generally conclude — and where the research is still developing.

What question is testosterone therapy meant to answer?

Testosterone is the main male sex hormone, although it is present and biologically important in everyone. It contributes to sexual function, the development and maintenance of muscle and bone, the production of red blood cells, and aspects of mood and energy. When the body does not make enough of it, a recognizable pattern of symptoms can follow. Testosterone therapy is the practice of adding testosterone from an outside source to raise levels back toward a typical range.

The central question the evidence tries to answer is deceptively simple: who genuinely benefits, and at what cost? That question is harder than it sounds, because the symptoms most often attributed to low testosterone — tiredness, low mood, reduced sex drive, difficulty maintaining muscle — are common and have many possible causes. A great deal of the research literature, and most of the disagreement, centers on separating people whose symptoms are truly driven by hormone deficiency from those whose symptoms come from something else.

Who guidelines say testosterone therapy is for

Major endocrine and urology guidelines broadly agree that testosterone therapy is intended for people with both consistent symptoms and clearly and repeatedly low testosterone measurements — a state usually described as hypogonadism. Guidance generally emphasizes confirming low levels on more than one morning blood sample before treatment is considered, because a single result can be misleading. Testosterone follows a daily rhythm, tends to be highest in the morning, and can dip temporarily during acute illness, poor sleep, or stress.

The distinction that runs through the guidelines is between treating a documented deficiency and treating ordinary, age-related changes. Testosterone tends to decline gradually with age, and guidelines are generally cautious about prescribing therapy purely to counteract aging in people whose levels are within typical ranges. Many guidelines also distinguish between a problem originating in the testes and one originating in the brain's signaling, because the cause influences both the workup and the conversation about fertility.

What the evidence broadly shows

Across the research literature, the most consistent signal is that testosterone therapy can improve sexual symptoms — such as low libido — in men with confirmed low levels. Evidence also points toward generally modest effects on mood, energy, body composition (more lean mass, less fat mass), and bone density. The size and durability of these effects vary considerably from person to person, and benefits are generally clearer in those who started with genuinely low levels rather than borderline ones.

For outcomes such as cognition, depression that is not linked to low testosterone, and general vitality in people with normal levels, the evidence is weaker and less consistent. Guidelines tend to describe these as areas where therapy should not be expected to help. A recurring theme is that the more clearly deficient a person is at the start, the more reliably the studies detect a benefit; in people near the lower edge of normal, the picture becomes murkier and expectations should be more modest.

Risks and what to monitor

Commonly discussed considerations include effects on red blood cell counts (testosterone can raise them, which is why blood counts are typically monitored), fertility (therapy can suppress the body's own sperm production), prostate health and monitoring, and possible skin or breast changes. These are not reasons to avoid therapy in everyone, but they are the reasons guidelines describe testosterone treatment as something to be monitored over time rather than started and forgotten.

Cardiovascular safety has been a long-running question. The broad direction of more recent evidence has been somewhat reassuring for appropriately selected patients, but the literature is still maturing and guidelines continue to call for individualized discussion rather than blanket reassurance.

Where the evidence is still developing

Open questions in the literature include the long-term cardiovascular and prostate effects across diverse populations, the best approach for younger people with borderline levels, and how different formulations — gels, injections, patches, and others — compare over many years for both effectiveness and safety. Because people enter these studies with different baseline health, ages, and reasons for low levels, results do not always generalize neatly from one group to another.

Testosterone in women

The role of testosterone therapy in women is a distinct and active research area. It is used in some contexts at much lower doses, and the evidence is more limited than it is for men. Here too, guidelines emphasize careful patient selection, conservative dosing, and monitoring, and they are explicit that much remains to be learned.

What it means for patients

This summary is educational and is not a recommendation to start, stop, or change any treatment. Decisions about testosterone therapy depend on confirmed laboratory results, symptoms, other health conditions, fertility plans, and personal priorities — a conversation for you and a qualified clinician. A reasonable mindset is to expect a careful diagnostic process before treatment, realistic rather than dramatic expectations, and ongoing follow-up afterward.

You may also find our treatments, conditions, hormones, and blood tests sections useful for background, and our studies index for related evidence overviews such as hormones and bone health.